Factor XII (FXII), a protein involved in blood clotting, is found at significantly higher levels in the blood of people…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
ANCA-associated vasculitis (AAV) patients who are older and taking pulses of methylprednisolone as an induction therapy are more likely…
Common variants in genes that encode proteins of the alternative complement pathway, a part of the immune system, may raise…
An 18-month fixed-schedule maintenance regimen of rituximab is better at keeping ANCA-associated vasculitis (AAV) in remission for up to…
A Phase 2 clinical trial testing Q32 Bio’s ADX-097 in people with ANCA-associated vasculitis (AAV) will be the…
Granulomatosis with polyangiitis (GPA) is the most common type of ANCA-associated vasculitis (AAV) in Italy and is linked…
People with ANCA-associated vasculitis (AAV) may present different lung involvement patterns depending on the type of disease and self-reactive…
A low dose of intravenous or into-the-vein methylprednisolone, a corticosteroid, is as safe and effective as a high dose at…
A protein fragment called Ba that’s produced when the alternative complement pathway is activated is found at high levels in…
AstraZeneca’s Fasenra (benralizumab) — approved for a rare type of asthma — does no worse than Nucala (mepolizumab)…